Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2021-01-26 2020-12-14
Drug Identification Number 02491362 02491362
Brand name METHOTREXATE SUBCUTANEOUS METHOTREXATE SUBCUTANEOUS
Common or Proper name METHOTREXATE SUBCUTANEOUS METHOTREXATE SUBCUTANEOUS
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size vial vial
ATC code L04AX L04AX
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-14 2020-12-14
Estimated end date 2021-01-08 2021-01-08
Actual end date 2021-01-25
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments